This comprehensive review explores the complex, context-dependent role of the transcription factor SOX9 in modulating immune responses within tumor microenvironments compared to normal tissues.
The transcription factor SOX9 is a pivotal, yet dualistic, regulator of the immune system, playing context-dependent roles in cancer immune escape, inflammatory diseases, and tissue repair.
This article synthesizes current research on the transcription factor SOX9 and its complex correlation with immune checkpoint markers across various cancers.
This article provides a comprehensive analysis of the SOX9 transcriptional network, a master regulator with critical, context-dependent roles in development, homeostasis, and disease.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing SOX9 gene editing in primary immune cells.
This comprehensive review addresses the critical challenge of improving SOX9 target specificity in therapeutic development.
The transcription factor SOX9 has emerged as a pivotal driver of therapy resistance across diverse cancer types, including gastric, ovarian, breast, and colorectal cancers.
SOX9 inhibition presents a promising therapeutic strategy for overcoming radioresistance and eradicating cancer stem cells in malignancies like gastrointestinal cancer.
The transcription factor SOX9 presents a significant paradox in cancer biology and immunotherapy, acting as both a potent oncogene and a crucial tissue repair factor.
This article explores the convergence of SOX9 gene editing and organoid technology for advanced immune function studies.